BR112015015938A2 - uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto - Google Patents

uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto

Info

Publication number
BR112015015938A2
BR112015015938A2 BR112015015938A BR112015015938A BR112015015938A2 BR 112015015938 A2 BR112015015938 A2 BR 112015015938A2 BR 112015015938 A BR112015015938 A BR 112015015938A BR 112015015938 A BR112015015938 A BR 112015015938A BR 112015015938 A2 BR112015015938 A2 BR 112015015938A2
Authority
BR
Brazil
Prior art keywords
phenylephrine
drug
respiratory tract
pharmaceutically acceptable
upper respiratory
Prior art date
Application number
BR112015015938A
Other languages
English (en)
Inventor
Campbell Atkinson Hartley
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of BR112015015938A2 publication Critical patent/BR112015015938A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/12Mucolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

resumo uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto uso de cloridrato de fenilefrina (ou uma forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol na produção de um medicamento combinado para tratamento de congestão das mucosas do trato respiratório superior, compreendendo a combinação de tais substâncias com excipientes, caracterizado pelo fato de o medicamento apresentar o cloridrato de fenilefrina (ou a forma alternativa farmaceuticamente aceitável de fenilefrina) e paracetamol em proporções adequadas, e o medicamento se destina, para a administração a um adulto de: a) 4 mg – 7,5 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável), em combinação com 950 mg – 1.000 mg de paracetamol; ou b) 5 mg – 7,5 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável de fenilefrina), em combinação com 600 mg – 700 mg de paracetamol; ou c) 6 mg – 8 mg de cloridrato de fenilefrina (ou uma quantidade equivalente de uma forma alternativa farmaceuticamente aceitável de fenilefrina), em combinação com 500 mg – 550 mg de paracetamol.
BR112015015938A 2013-02-04 2014-01-07 uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto BR112015015938A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NZ60665913 2013-02-04
NZ61013213 2013-05-02
NZ61391813 2013-08-02
NZ61802713 2013-11-20
PCT/NZ2014/000001 WO2014120021A1 (en) 2013-02-04 2014-01-07 A combination medicament comprising phenylephrine and paracetamol

Publications (1)

Publication Number Publication Date
BR112015015938A2 true BR112015015938A2 (pt) 2017-07-11

Family

ID=51262632

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015015938A BR112015015938A2 (pt) 2013-02-04 2014-01-07 uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto

Country Status (16)

Country Link
EP (1) EP2830605B8 (pt)
CN (2) CN104936585B (pt)
AP (1) AP2015008704A0 (pt)
BR (1) BR112015015938A2 (pt)
CA (1) CA2893836C (pt)
EC (1) ECSP15033649A (pt)
LU (1) LU92526B1 (pt)
MX (2) MX2015009681A (pt)
PE (1) PE20151282A1 (pt)
PH (1) PH12015501294A1 (pt)
PL (1) PL2830605T3 (pt)
RS (1) RS64807B1 (pt)
SG (1) SG11201504389QA (pt)
TW (1) TW201434464A (pt)
WO (1) WO2014120021A1 (pt)
ZA (1) ZA201504080B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
ES2863988T3 (es) 2015-05-21 2021-10-13 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Formulaciones farmacéuticas con mejor solubilidad y estabilidad

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260600A (en) * 1979-10-22 1981-04-07 Ronald Valle Method of treating depression
US20040162273A1 (en) * 2003-01-23 2004-08-19 The Procter & Gamble Company Powder pharmaceutical compositions
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
WO2009012590A1 (en) 2007-07-23 2009-01-29 Kingsway Pharmaceuticals Inc. Therapeutic formulations for the treatment of cold and flu-like symptoms
WO2009117403A1 (en) * 2008-03-17 2009-09-24 The Procter & Gamble Company User-customizable dosing system
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US20110104272A1 (en) * 2009-11-05 2011-05-05 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine
WO2012090218A1 (en) * 2010-12-30 2012-07-05 Zota Health Care Ltd Synergistic effects of the combination of the specific compounds with paracetamol and their effects on various diseases

Also Published As

Publication number Publication date
CN104936585A (zh) 2015-09-23
MX2021001845A (es) 2021-05-13
MX2015009681A (es) 2016-07-11
RS64807B1 (sr) 2023-12-29
ECSP15033649A (es) 2015-11-30
TW201434464A (zh) 2014-09-16
AP2015008704A0 (en) 2015-09-30
CN107811999A (zh) 2018-03-20
LU92526B1 (fr) 2014-12-22
CA2893836C (en) 2017-05-02
EP2830605B1 (en) 2023-09-27
PL2830605T3 (pl) 2024-02-19
CN104936585B (zh) 2017-11-14
CA2893836A1 (en) 2014-08-07
SG11201504389QA (en) 2015-08-28
PE20151282A1 (es) 2015-10-04
TWI514998B (pt) 2016-01-01
EP2830605B8 (en) 2023-11-08
WO2014120021A1 (en) 2014-08-07
EP2830605A4 (en) 2015-02-04
ZA201504080B (en) 2016-04-28
EP2830605A1 (en) 2015-02-04
PH12015501294A1 (en) 2015-08-24

Similar Documents

Publication Publication Date Title
CL2016000530A1 (es) Tratamiento de la osteoartritis y del dolor (divisional de sol. n°2298-13).
BR112015025464A2 (pt) coagonistas do receptor de glp-1/glucagon estáveis, prolongados para uso médico
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
BR112015018168A2 (pt) inibidores de rock suaves
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
EA201591363A1 (ru) Аналоги тиадиазола и способы лечения состояний, связанных с дефицитом smn
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
MX2021002321A (es) Nuevos metodos.
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
EA201690974A1 (ru) Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
TR201819662T4 (tr) Çocukluk çağı hipertansiyon tedavisinde kullanılan enalapril içeren ağızda dağılan film bileşimi.
BR112015015938A2 (pt) uso de cloridrato de fenilefrina e paracetamol, medicamento, método de tratamento de congestão das mucosas do trato respiratório superior em um humano adulto
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
EA202090164A1 (ru) Изотретиноиновые перорально-слизистые композиции и способы их применения
BR112019001134A2 (pt) uso de lactama e composição farmacêutica
CY1120749T1 (el) Φαρμακευτικες δοσολογικες μορφες
IN2013MU03428A (pt)
CO2018010142A2 (es) Proceso de preparación de fórmulas solidas de mesalazina
ES2475942B1 (es) Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
AR095149A1 (es) Medicamento que comprende fenilefrina y paracetamol
CR20150363A (es) Combinación de un medicamento que comprende fenilefrina y paracetamol
AR091633A1 (es) Solucion inyectable de acetaminofen para su administracion por via espinal

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]